The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine
Abstract
CONTEXT: A conjugate vaccine targeting 7 pneumococcal serotypes was licensed for young children in 2000. In contrast to the 23-valent polysaccharide vaccine used in adults, the 7-valent conjugate vaccine affects pneumococcal carriage and transmission. Early after its introduction, incidence of invasive pneumococcal disease declined among older adults, a group at high risk for pneumococcal disease. OBJECTIVE: To determine among adults aged 50 years or older whether incidence of invasive pneumococcal disease, disease characteristics, or the spectrum of patients acquiring these illnesses have changed over the 4 years since pneumococcal conjugate vaccine licensure. DESIGN, SETTING, AND POPULATION: Population-based surveillance of invasive pneumococcal disease in 8 US geographic areas (total population, 18,813,000), 1998-2003. MAIN OUTCOME MEASURES: Incidence of invasive pneumococcal disease by pneumococcal serotype and other characteristics; frequency among case patients of comorbid conditions and other factors influencing mortality. RESULTS: Incidence of invasive pneumococcal disease among adults aged 50 years or older declined 28% (95% confidence interval [CI], -31% to -24%), from 40.8 cases/100,000 in 1998-1999 to 29.4 in 2002-2003. Among those aged 65 years or older, the 2002-2003 rate (41.7 cases/100,000) was lower than the Healthy People 2010 goal (42 cases/100,000). Among adults aged 50 years or older, incidence of disease caused by the 7 conjugate vaccine serotypes declined 55% (95% CI, -58% to -51%) from 22.4 to 10.2 cases/100,000. In contrast, disease caused by any of the 16 serotypes only in polysaccharide vaccine did not change, and disease caused by serotypes not in either vaccine increased somewhat, from 6.0 to 6.8 cases/100,000 (13%; 95% CI, 1% to 27%). Between 1998-1999 and 2002-2003, the proportion of case-patients with human immunodeficiency virus infection increased from 1.7% (47/2737) to 5.6% (124/2231) (P<.001), and those with any comorbid condition that is an indication for pneumococcal polysaccharide vaccination increased from 62.3% (1842/2955) to 72.0% (1721/2390) (P<.001). CONCLUSIONS: Our findings indicate that use of conjugate vaccine in children has substantially benefited older adults. However, persons with certain comorbid conditions may benefit less than healthier persons from the indirect effects of the new vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
Bogaert, D., de Groot, R., & Hermans, P. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00938-7 · Cited by 1,929
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,051
(1997) · PsycEXTRA Dataset · doi:10.1037/e547512006-001 · Cited by 1,000
Active Bacterial Core Surveillance of the Emerging Infections Program Network
Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010114 · Cited by 592
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.2.223 · Cited by 589
Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate Vaccine
Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., & Klugman, K. P. (1999) · The Journal of Infectious Diseases · doi:10.1086/315009 · Cited by 515
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Yu, V. L., Chiou, C. C. C., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Baddour, L. M., Luna, C. M., Snydman, D. R., Ip, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/377534 · Cited by 451
Carriage of pneumococci after pneumococcal vaccination
Obaro, S. K., Adegbola, R., Banya, W., & Greenwood, B. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65585-7 · Cited by 325
Black, S., Shinefield, H., Baxter, R., Austrian, R., Bracken, L., Hansen, J., Lewis, E., & Fireman, B. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000129685.04847.94 · Cited by 324
(2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00274-4 · Cited by 284
Failure of Intensive Care Unit Support to Influence Mortality From Pneumococcal Bacteremia
Hook, E. W. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330320053032 · Cited by 262
United States Census 2000 population with bridged race categories.
Ingram, D. D., Parker, J. D., Nathaniel Schenker, A., Weed, J. A., Hamilton, B. E., Arias, E., & Madans, J. H. (2003) · PubMed · Cited by 226
Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era
Mufson, M. A. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.134.3.505 · Cited by 189
Serotype-specific mortality from invasive Streptococcus pneumoniaedisease revisited
Martens, P., Worm, S. W., Lundgren, B., Konradsen, H. B., & Benfield, T. (2004) · BMC Infectious Diseases · doi:10.1186/1471-2334-4-21 · Cited by 158
Moore, M. R., Hyde, T. B., Hennessy, T. W., Parks, D. J., Reasonover, A. L., Harker‐Jones, M., Gove, J. E., Bruden, D. L., Rudolph, K. M., Parkinson, A. J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/425422 · Cited by 128
Givon‐Lavi, N., Fraser, D., & Dagan, R. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000069760.65826.f2 · Cited by 117
Rubins, J. B., Alter, M. D., Loch, J., & Janoff, E. N. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5979-5984.1999 · Cited by 106
Fry, A. M., Zell, E. R., Schuchat, A., Butler, J. C., & Whitney, C. G. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00451-6 · Cited by 65
Talbot, T. R., Poehling, K. A., Hartert, T. V., Arbogast, P. G., Halasa, N., Mitchel, E. F., Schaffner, W., Craig, A. S., Edwards, K. M., & Griffin, M. R. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133046.60555.de · Cited by 48
Cited by
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 2,323
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationThe role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease
Kadioglu, A., Weiser, J. N., Paton, J. C., & Andrew, P. W. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1871 · Cited by 1,146
Insights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
Metadata
- Authors
- Lexau, C. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-10-26
- Volume
- 294
- Issue
- 16
- Pages
- 2043
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2098483219
- Cited by
- 671
- References
- 24
- FWCI
- 33.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.